日本語 >>
TOP page
Current specialization
Journal Articles
Presentations
(Last updated : 2026-09-03 10:42:24)
Akira Hirano
Department
Kawasaki Medical School Kawasaki Medical School, Department of Nephrology and Hypertension,
Position
Instructor
■
Current specialization
Nephrology
■
Journal Articles
1.
2026/07/13
Sequential Management Enabling Continuation of Peritoneal Dialysis in Autosomal Dominant Polycystic Kidney Disease Despite Multiple Complications
2.
2026/04
Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease
3.
2026/01/01
Endothelial dysfunction accelerates AKI to CKD transition by promoting β-catenin activation in macrophages
4.
2026
Unexpected drainage failure in a patient receiving long-term peritoneal dialysis.
5.
2025/11/06
The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria
6.
2025/11
The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria.
7.
2024/11/02
ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice
8.
2024/11
Effects of Beraprost on Intestinal Microcirculation and Barrier Function in a Mouse Model of Renal Failure. inpress
9.
2023/09
Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis.
10.
2023
The deficient of eNOS-NO pathway exacerbates kidney dysfunction
via inflammasome activation in diabetic kidney disease
Display 5 items
Display all(10)
■
Presentations
1.
2026/03/30
Association Between serum potassium levels and CKD Progression in Japan: A Retrospective Cohort Study Using the J-CKD-DB-Ex Registry (Poster notice,General)
2.
2026/03/30
ASSOCIATION BETWEEN SYSTEMIC INFLAMMATION AND CHRONIC KIDNEY DISEASE PROGRESSION IN JAPAN: A RETROSPECTIVE
COHORT STUDY USING THE J-CKD-DB-EX REGISTRY (Poster notice,General)
3.
2026/03/29
Effects of Non-steroidal Mineralocorticoid Receptor Blocker Esaxerenone on Glomerular Hemodynamics in type 2 Diabetic Kidney Disease (Poster notice,General)
4.
2026/03/29
PROTECTIVE ROLE OF FINERENONE AGAINST PODOCYTE INJURY THROUGH MR–TRPC PATHWAY INHIBITION IN DIABETIC KIDNEY
DISEASE (Poster notice,General)
5.
2025/11/08
Mineralocorticoid Receptor-TRPC5 Axis Drives Macrophage-Mediated Inflammation in Diabetic Kidney Disease (Speech,General)
6.
2024/10/24
Elucidation of the Renoprotective Effects of SGLT2 Inhibitors in Nondiabetic CKD (Poster notice,General)
7.
2024/09/15
Elucidation of the Molecular Mechanism of Albuminuria Improvement by Non-Steroidal Mineralocorticoid Receptor (MR) Antagonists Finerenone. (Poster notice,General)
8.
2024/09/15
Endothelial Dysfunction Fuels Progression from Acute to Chronic Kidney Disease through Macrophage-Mediated β-Catenin Activation (Poster notice,General)
9.
2024/09/15
Impaired Glomerular Epithelial Cell sGC Activation Promotes Glomer- Significance of Glomerular Epithelial Cell sGC Activation via eNOS-NO Pathway in Diabetic Kidney Disease (Poster notice,General)
10.
2024/09/15
SGLT2 Inhibition suppresses residual nephron glomerular hyperfiltration in Non-Diabetic Chronic Kidney Disease (Poster notice,General)
11.
2024/09/14
Elucidation of glomerular hemodynamic changes by mineralocorticoid receptor blocker esaxerenone in diabetic kidney disease (Poster notice,General)
Display 5 items
Display all(11)